United States

People: Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

23 Mar 2018
Change (% chg)

$-0.49 (-2.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Drapkin, Kimberlee 

Ms. Kimberlee Cobleigh Drapkin, CPA is the Chief Financial Officer and Treasurer of Jounce Therapeutics, Inc. Ms. Drapkin has served as our chief financial officer since August, 2015, and our treasurer since February 2013. From 2009 to 2015, Ms. Drapkin was the owner of KCD Financial LLC, through which she served as our interim chief financial officer from 2012 to August 2015, and consulted for numerous biotechnology companies. Previously, Ms. Drapkin served as the chief financial officer of Predix Pharmaceuticals holdings, Inc., or Predix, from 2005 to 2006, and, after Predix was acquired by EPIX Pharmaceuticals, Inc., or EPIX, as chief financial officer of EPIX from 2006 to 2009. Earlier in her career, from 1995 to 2005, Ms. Drapkin served in a variety of roles at Millennium Pharmaceuticals, Inc., including as director of finance. Ms. Drapkin began her career at PricewaterhouseCoopers LLP and holds a B.S. in accounting from Babson College.

Basic Compensation

Total Annual Compensation, USD 408,700
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 466,545
Fiscal Year Total, USD 875,245

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --